Financials in USD. Standardized financial statements.
A compact view of how Lucid Diagnostics Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.71M | $4.35M | $2.43M | $377,000 | $500,000 | $0 | $0 | $0 |
| Revenue Growth? | +8.3% | +79.0% | +544.0% | -24.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $7.54M | $8.27M | $8.48M | $3.61M | $585,000 | $0 | $0 | $0 |
| Gross Profit? | -$2.84M | -$3.92M | -$6.05M | -$3.24M | -$85,000 | $0 | $0 | $0 |
| Gross Margin? | -60.3% | -90.2% | -249.2% | -858.6% | -17.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $46.80M | $42.13M | $42.43M | $52.93M | $27.33M | $8.28M | $4.42M | $1.13M |
| Operating Income? | -$49.64M | -$46.05M | -$48.48M | -$56.17M | -$27.42M | -$8.28M | -$4.42M | -$1.13M |
| EBITDA? | -$48.77M | -$44.34M | -$49.75M | -$54.23M | -$27.41M | $482 | $0 | $562,957 |
| Income Before Tax | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | -$4.42M | -$1.13M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | -$4.42M | -$1.13M |
| EPS? | $-0.69 | $-1.05 | $-1.26 | $-1.55 | $-0.78 | $-0.22 | $-0.12 | $-0.03 |
| Diluted EPS? | $-0.69 | $-1.05 | $-1.26 | $-1.55 | $-0.78 | $-0.22 | $-0.12 | $-0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality